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Abstract
Background: Chronic Obstructive Pulmonary Disease (COPD) is among the leading causes of death in the world,
and further increases in the prevalence and mortality are predicted. Delay in diagnosing COPD appears frequently
even though current consensus guidelines emphasize the importance of early detection of the disease. The aim of
the present study is to evaluate the effectiveness of a screening programme in general practice.
Methods/Design: Subjects aged 65 years and older registered with a General Practitioner (GP) in the eastern
Copenhagen will receive a written invitation and a simple questionnaire focusing on risk factors and symptoms of
COPD. Subjects who meet the following criteria will be encouraged to undergo spirometric testing at their GP:
current smokers, former smokers, and subjects with no smoking history but who have dyspnea and/or chronic
cough with sputum.
Discussion: The Copenhagen COPD Screening Project evaluates the effectiveness of a two-stage screening
program for COPD in general practice and provides important information on how to organize early detection of
COPD in general practice in the future.
Background
C h r o n i cO b s t r u c t i v eP u l m o n a r yD i s e a s e( C O P D )i s
among the leading causes of chronic morbidity and
mortality throughout the world. In 2002, COPD was the
fifth leading cause of death in the world, and further
increases in its prevalence and mortality are predicted
[1-4]. COPD is characterised by a slowly progressing air-
flow limitation caused by chronic inflammation in the
bronchioles. Early-stage COPD is often symptomless,
although coughing with sputum production is common.
Smoking is by far the most important risk factor,
accounting for 85-90% of all cases [3,4]. According to
recent studies, at least 25% of smokers without initial
disease will have clinically significant COPD after 25
years [5-8].
Early detection of COPD is crucial for promoting
smoking cessation and instituting pharmacological and
non-pharmacological therapy before patients reach
symptomatic and costly stages of disease. Smoking ces-
sation is followed by a marked reduction in the
irreversible accelerated decline in FEV1 (forced expira-
tory volume in first second) associated with the develop-
ment of the disease [3,4]. Even though current
consensus guidelines, such as the Global Initiative for
Chronic Obstructive Lung Disease (GOLD) and other
national recommendations, emphasize the importance of
early detection, delay in diagnosing COPD is still com-
mon [3,9-11]. A recent Danish study shows that
approximately 430,000 Danes suffer from COPD, and at
least one third are undiagnosed [12]. This is consistent
with other recent estimates indicating that 25% to 50%
of patients in the western societies with clinically impor-
tant disease are undetected or misdiagnosed [3]. In gen-
eral, a delayed diagnosis of COPD results from the
patient’s gradual adaptation to decreasing lung function
(patients delay) and, in some cases, lack of awareness of
or response to the patient’ss y m p t o m sf r o mp h y s i c i a n s
(doctors delay) [13-15]. For instance, in a Dutch study,
74% of all subjects with symptoms or signs of COPD or
asthma never consulted their GP for respiratory com-
plaints, regardless of the severity of symptoms or lung
function impairment [13].
The GOLD international guidelines for COPD, as well
as national guidelines, advise spirometry as the gold
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lung function. Primary care physicians are in an ideal
position to detect early-stage COPD and perform spiro-
metry to confirm the diagnosis [3,9,11]. The present
study emphasizes the important role of the GP in the
early diagnosis of COPD. In Denmark, 99% of citizens
are listed with a GP, i.e. is having their own GP. A sub-
stantial number of citizens are having this specific GP
for a long period of their life and only shift to another
GP if they leave the area, disagreement happens or if
the GP retires. The GPs play a key role within the Dan-
ish health system as the first point of contact for
patients and the gatekeeper to hospitals, specialists, and
other types of multidisciplinary care. This system sup-
ports the development of long-term relationships
between patients and GPs and gives the latter the ability
to perform preventive efforts, such as spirometry, free of
charge [16,17].
Current strategies to improve early detection
In previous studies, mainly two methods have been used
to increase the rate of early diagnosis of COPD: screen-
ing of high-risk populations and case-finding. High-risk
screening studies offer spirometry to all people in a
selected population who meet certain criteria; often
smokers, whereas case finding studies offer tests only to
those who consult a GP for other health problems.
Their advantages and disadvantages make them comple-
mentary approaches [18-24].
Effective case-finding depends on patient contact with
GPs. In 2005, approximately 15% of the Danish popula-
tion had no contact with their own or other GPs [25].
Although case finding of COPD in general practice has
proven to be a more realistic approach than screening
entire populations, it still leaves out a significant propor-
tion of subjects at risk. Furthermore, case-finding
assumes that every GP is fully aware of patients at risk
for COPD and that they perform spirometry when
needed. According to a recent study performed at Oes-
terbro, in eastern Copenhagen, 3,000 subjects above 65
years were at risk of COPD in 2007 [12]. However, only
224 (7.5%) spirometries were performed in 2007 among
the 3000 citizens at risk. Furthermore these 224 spirom-
eties were performed by one of the 56 General Practi-
tioners at Oesterbro (Centralized GP observation),
indicating that in average each GP perform four spiro-
metries per year.
Screening and case-finding programs have mainly
focused on smokers and former smokers. However, the
present model also includes subjects with no smoking
history, but with a history of dyspnoea and/or chronic
cough with sputum [15,19,20,22-24,26-28].
Aim of the study
The aim of the study is two-fold. First, we will assess if a
short, mailed questionnaire, based on patient-reported
information can serve as a first-level screening tool for
the identification of individuals at risk for COPD. Sec-
ondly, we would like to assess if the self-administrated
questionnaire can be used to prompt individuals at risk
to undergo spirometric testing at their GP for an early
diagnosis.
Methods/design
Setting and population
This study is collaboration between the City administra-
tion of Copenhagen, Bispebjerg University Hospital, and
GPs in the local area of Oesterbro. It will be performed
in eastern Copenhagen, which has a population of
67,330 citizens and 56 GPs. All individuals, aged 65
years and older, registered with one of the 56 general
practices will be selected for the study. The Capital
Region will provide the subjects and their addresses
from the Danish Civil Registration System (CPR), in
which all Danish citizens have a personal identification
number. All subjects from the study population will
receive a short questionnaire in order to identify those
at risk of COPD. The participating GPs will be asked to
screen every subject at risk who requests an appoint-
ment for spirometric testing (Figure 1). Inclusion criteria
are shown in Figure 2. Subjects will be excluded from
the study if they are nursing home residents, since we
expect that most of them will not be able to visit their
GP without help. Subjects not registered with a general
practice, or subjects who change from one GP to
another after selection but before the invitation letters
are mailed, will also be excluded. The number of
excluded subjects within each of the above listed reasons
will be counted.
Interventions
Invitation to spirometry/questionnaire
All subjects will receive an invitation letter by mail con-
taining a small booklet about the study and general
information about COPD, its prevalence, and the rela-
tion between the disease and smoking. They will be
asked to complete a questionnaire indicating their
smoking status and potential COPD symptoms (Figure
3). Subjects with at least one positive answer will be
encouraged to undergo spirometry at their GP and
asked to indicate whether they expect to contact their
GP for an appointment. Subjects with no smoking his-
tory or symptoms will be asked to return the question-
naire with no further action. A preaddressed postage-
paid envelope will be included. A first (and second)
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Page 3 of 7reminder will be sent to non-responders. Patients with a
previous diagnosis of COPD will be invited to partici-
pate. To prevent excessive GP workloads, invitations
will be sent in three rounds, and GPs will receive a list
of patients receiving invitation letters.
To increase participation rates, advertisements will be
placed in the local newspapers three times during the
study period. The project manager will also visit local
senior clubs to provide information on the project and
to encourage subjects to participate.
Pulmonary function testing and diagnostic criteria of COPD
Spirometry will be performed using the different spi-
rometers available in each practice; as not all GPs have
a spirometer, an EasyOne® spirometer will be available
to each practice that needs one for the duration of the
project. Spirometry will be performed by the GP or
practice nurse/assistant. Subjects enrolled in a General
Practice office that does not offer spirometry, are invited
to contact the Health Care Centre in eastern Copenha-
gen for a lung function test. A specially trained project
nurse will perform spirometry and forward results to
the patient’s GP, who is responsible for the interpreta-
tion of the test. All spirometry performed by GPs will
be re-evaluated by an experienced physician at
Department of Respiratory Medicine, Bispebjerg Univer-
sity Hospital. Written informed consent will be obtained
from all subjects prior to spirometry.
Forced vital capacity (FVC) and forced expiratory
volume in first second (FEV1)w i l lb em e a s u r e d ,a n dt h e
FEV1/FVC-ratio will be calculated. The FVC and FEV1
used will be the largest value obtained from any of three
technically satisfactory tests that vary no more than 5%
or 100 ml, whichever is greater. Post-bronchodilator
FEV1/FVC and FEV1 measurements will not be per-
formed at this occasion.
Spirometry measurements will be evaluated by com-
parison to reference values based on age, height, sex,
and race [29]. Spirometry results will be classified
according to the GOLD guidelines (Table 1) [3]. It is
the GPs responsibility to initiate medical treatment in
patients diagnosed with COPD and, if necessary, to refer
patients to a pulmonary rehabilitation programme in
accordance with the local COPD disease management
programme.
According to a scale of fees agreed upon by the Orga-
nisation of General Practitioners and the Danish
Regions, a special fee-for-service payment to the GP for
performing spirometry will be posted. To create an
Figure 2 Inclusion criteria for spirometry.
Figure 3 Questionnaire.
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be slightly higher for performing spirometry for the
study, as compared to usual compensation for spirome-
try. The higher payment will compensate GPs for
required data collection. The patients will not receive
any economic compensation.
Bispebjerg University Hospital
If the GP or the nurse at the health care centre is not
able to carry out a proper test or finds it difficult to
interpret the result, the patient will be referred to the
outpatient clinic at the Department of Pulmonary Medi-
cine at Bispebjerg University Hospital. At the clinic a
specialized COPD nurse will perform the test and
inform the patient and the patient’s GP about the result.
Education seminar/ongoing support in general practice
Five studies have shown that implementation of spiro-
metry in general practice is feasible if adequate training
is used and interpretation of spirometry is provided
[30-34]. However, a Danish study of 2549 patients
shows that spirometry data documenting presence of
airway obstruction are only available in 50% of patients
diagnosed with COPD and that severity assessment
(based on FEV1 % predicted value) is only conducted in
30% of patients diagnosed with COPD [35]. These
results underscore the need for further education and
support in the use of spirometry in general practice in
Denmark.
Therefore, prior to the screening, all GPs and their
clinical staff will be invited to participate in a two-hour
course that includes aspects of diagnosis and manage-
ment of COPD, as well as training in performance and
interpretation of spirometry. Continuous technical and
methodological support is available to the participating
GPs through the screening period. The course and
ongoing support will be carried out by a physician from
the Department of Pulmonary Medicine, Bispebjerg Uni-
versity Hospital, and the project leader.
In addition to the course, all GPs will receive written
instructions on how to perform spirometry and interpret
results and on medical treatment and referral proce-
dures for pulmonary rehabilitation in accordance to the
GOLD-guidelines. They will also receive a list of names
and identification numbers for patients invited to
participate.
Home care Oesterbro
All nurses and home helpers at Home care Oesterbro
will be invited to participate in a two-hour course that
will include a short introduction to the project, informa-
tion on symptoms of COPD, treatment, and how to
help COPD patients to cope with daily life. The course
will be carried out by a specialised nurse in COPD and
the project leader. The purpose is to increase participa-
tion; patients receiving home care will typically be the
weakest of the invited population and some may need
help to respond to the invitation letter.
Expected patient volume
A calculation of the expected patient volume is shown
in figure 4.
Outcome measures
To estimate the effectiveness of the questionnaire as a
first-level screening tool for the identification of subjects
at risk, we will look at the response rates to the ques-
tionnaire and the number of subjects at risk. Secondly,
we will measure the interest in undergoing spirometry
among high-risk subjects as measured by the answers to
the questionnaire and the number of spirometries per-
formed. In regard to the number of performed spirome-
tries, we will compare participation rates among those
who have been told to contact their GP and those who
have been told to contact the local health care centre.
Finally, we will assess the prevalence and severity of
COPD among subjects who undergo spirometry.
Planned analysis
T oa n a l y s et h er e s p o n s er a t et ot h eq u e s t i o n n a i r ea n d
the number of people at risk, descriptive statistics will
be used. The association between individuals expecta-
tion to undergo spirometry and patient characteristics
will be evaluated as well as the association between hav-
ing spirometry performed and patient characteristics.
Logistic regression will be used to estimate the odds of
expected participation and actual participation (spirome-
try) with age, sex and smoking status as the independent
variables. Comparisons between the group told to con-
tact their GP for a test and the group told to contact
the health care centre will be made with Chi-square
tests. Finally the prevalence and severity of COPD will
be estimated with descriptive statistics.
Ethical approval
The study will be conducted according to the principles
of the Helsinki declaration. The study is approved by
the Danish Scientific Ethics Committee under ref. no H-
Table 1 Spirometric Classification of COPD Severity.
Based on Post-Bronchodilator FEV1
Stage I: Mild FEV1/FVC < 0,70
FEV1 ≥ 80% predicted
Stage II: Moderate FEV1/FVC < 0,70
50% ≤ FEV1 < 80% predicted
Stage III: Severe FEV1/FVC < 0,70
30% ≤ FEV1 < 50% predicted
Stage IV: Very Severe FEV1/FVC < 0,70
FEV1 < 30% predicted or
FEV1 < 50% predicted plus
chronic respiratory failure
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Page 5 of 7B-2007-057, by the Danish Data Protection Agency and
by the Committee of Multipractice Studies in General
Practice under ref. no: MPU 16-2007.
Project timeline
The study will be completed between February 2008 and
February 2009.
Discussion
The current study will be able to assess whether a short,
mailed questionnaire based on patient-reported informa-
tion can serve as a first-level screening tool for the iden-
tification of subjects at risk of COPD. Secondly it will be
able to illustrate whether a focused questionnaire can
prompt individuals at risk to undergo spirometric test-
ing at their GP for an early diagnosis. It will be more
economically efficient than broad population-level
screening for COPD and reach a larger population than
is possible through case-finding alone. By including not
only smokers, but also former smokers and individuals
with no history of smoking, but with a history of either
dyspnea, chronic cough, or both, we will reach the lar-
gest possible population at risk.
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